Global Opioids Drug Sale, Insights Market Research Report 2021-2027
- IFF4169563
- 114 Pages
- January 2021
- Pharmaceuticals
The Opioids Drug market was valued at USD xx Million in 2021. It is projected to reach USD xx Million by 2027, growing at a CAGR of xx% from 2021. Europe, North America, and Asia-Pacific are still the main markets of Opioids Drug. Opioids Drug has low penetration in India, the Middle East and Africa, which makes these markets have great market potential. Market players are responding to new opportunities by expanding their global presence and product offerings. On the one hand, Opioids Drug manufacturers are dedicated to lowering their manufacturing cost; on the other hand, they try to provide more qualified products to customers. Besides, they are trying to broaden the applications of Opioids Drug.
This report includes estimations of the market size in terms of value (USD million). Both, top-down and bottom-up approaches have been used to estimate and validate the size of the Opioids Drug market and to estimate the size of various other dependent submarkets in the overall market. This research study involved the extensive usage of both primary and secondary data sources.
The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges.
Main content of the study are:
To define, segment, and forecast the size of the Opioids Drug market with respect to type, application and region
To understand market conditions, company ranking, market structure, growth drivers by report
To historical and forecast the data of the market segments with respect to United States, EU, CIS, China, India, Japan, SEA, South America, Middle East, Oceania and the Rest of the World
To provide detailed information about the crucial factors that are influencing the growth of the market (drivers, restraints, opportunities, and challenges)
To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
The major players in global market include
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
J&J
Endo
Pfizer
INSYS
Mylan
Hikma
Egalet
Geographically, this report is segmented into several key Regions, with production, consumption, revenue, market share and growth rate of Opioids Drug in these regions, from 2013 to 2024 (forecast), covering
North America
EU
CIS
China
India
Japan
SEA
South America
Middle East
Oceania
Row
On the basis of product, the Opioids Drug market is primarily split into
Oxycodone
Hydromorphone
Codeine
Fentanyl
Others
On the basis on the end users/applications, this report covers
Pain Relief
Anesthesia
Others
Chapter 1, to describe Opioids Drug Introduction, product types, technology, industrial chain, market risk, industry policy;
Chapter 2, to analyze of Opioids Drug industry raw material and manufacturing cost;
Chapter 3, to analyze the major manufacturers of Opioids Drug, with capacity, production, revenue, and price of Opioids Drug, from 2016 to 2021;
Chapter 4, to show the global market by regions, with capacity, production, revenue and market share of Opioids Drug, for each region, from 2016 to 2021;
Chapter 5, to show the global market by regions, with sales, import, export and market share of Opioids Drug, for each region, from 2016 to 2021;
Chapter 6 and 7, to analyze the market by countries, by type and by application with sales, revenue and market share by key countries in these regions;
Chapter 8, to analyze the major manufacturers of Opioids Drug, with basic information, and data of Opioids Drug, from 2016 to 2021;
Chapter 9 and 10, to describe Opioids Drug sales channel, distributors and competitive products
Chapter 11, to analyze new project investment feasibility
Chapter 12, Opioids Drug market forecast, by regions, type and application, with production, sales and revenue, from 2021 to 2027;
1 Opioids Drug Overview
1.1 Product Overview of Opioids Drug
1.1.1 Definition of Opioids Drug
1.1.2 Specifications of Opioids Drug
1.2 Opioids Drug Segment by Types
1.2.1 Global Opioids Drug Production Market Share by Types in 2021
1.2.2 Oxycodone
1.2.3 Hydromorphone
1.2.4 Codeine
1.2.5 Fentanyl
1.2.6 Others
1.3 Opioids Drug Segment by Technology
1.4 Global Opioids Drug Segment by Applications
1.4.1 Global Opioids Drug Consumption Comparison by Applications (2016-2027)
1.4.2 Pain Relief
1.4.3 Anesthesia
1.5 Study Objectives and Content
1.6 Detailed Data Sources
2 Opioids Drug Raw Material and Manufacturing Cost Analysis
2.1 Opioids Drug Key Raw Materials Analysis
2.1.2 Price Trend of Key Raw Material A
2.1.4 Price Trend of Key Raw material B
2.3 Manufacturing Cost Structure Segment
2.3.1 Manufacturing Cost Structure Segment
2.3.2 Manufacturing Expenses Cost Structure Segment
2.4 Labor Costs Analysis by Regions
2.4.1 North America Costs Analysis
2.4.2 EU Costs Analysis
2.4.3 CIS Costs Analysis
2.4.4 China Costs Analysis
2.4.5 India Costs Analysis
2.4.6 Japan Costs Analysis
2.5 Manufacturing Process Analysis of Opioids Drug
2.6 Industry Policy Analysis of Opioids Drug
2.6.1 Direct Support for Policies and Macroeconomic Policies
2.6.2 Unfavorable Policy
3 Global Opioids Drug Market Share by Manufacturers
3.1 Global Opioids Drug Capacity, Production and Share by Manufacturers (2016-2021)
3.1.2 Major Manufacturer Production and Share by Manufacturers (2016-2021)
3.2 Major Manufacturer Revenue (Million USD) and Share by Manufacturers (2016-2021)
3.3 Global Opioids Drug Average Price by Manufacturers (2016-2021)
3.4 Opioids Drug Market Concentration Rate Analysis
3.4.1 Opioids Drug Market Concentration Rate
3.4.2 Opioids Drug Market Share of Top 3 and Top 5 Manufacturers
3.5 Opioids Drug Industry Mergers & Acquisitions, Expansion News
3.6 Potential Manufacturer or New Manufacturers
4 Global Opioids Drug Production by Regions (2016-2021)
4.1 Global Opioids Drug Capacity and Market Share by Regions (2016-2021)
4.2 Global Opioids Drug Production and Market Share by Regions (2016-2021)
4.3 2021 Global Opioids Drug Supply and Price by Season
4.4 Global Opioids Drug Revenue and Market Share by Regions (2013-2023)
4.4.1 Opioids Drug Market Size (Million USD) Comparison by Regions
4.4.2 North America Opioids Drug Status and Prospect (2016-2027)
4.4.3 EU Opioids Drug Status and Prospect (2016-2027)
4.4.4 CIS Opioids Drug Status and Prospect (2016-2027)
4.4.5 China Opioids Drug Status and Prospect (2016-2027)
4.4.6 India Opioids Drug Status and Prospect (2016-2027)
4.4.7 SEA Opioids Drug Status and Prospect (2016-2027)
4.4.8 South America Opioids Drug Status and Prospect (2016-2027)
4.4.9 Middle East Opioids Drug Status and Prospect (2016-2027)
4.4.10 Oceania Opioids Drug Status and Prospect (2016-2027)
4.4.11 Row Opioids Drug Status and Prospect (2016-2027)
4.5 Global Opioids Drug Price by Regions (2016-2027)
4.6 Global Opioids Drug Capacity, Production, Revenue (Million USD), Price and Gross Margin (2016-2021)
5 Global Opioids Drug Consumption by Regions (2016-2021)
5.1 Global Opioids Drug Consumption by Regions (2016-2021)
5.2 North America Opioids Drug Consumption (2016-2021)
5.3 EU Opioids Drug Consumption (2016-2021)
5.4 CIS Opioids Drug Consumption (2016-2021)
5.5 China Opioids Drug Consumption (2016-2021)
5.6 India Opioids Drug Consumption (2016-2021)
5.7 Japan Opioids Drug Consumption (2016-2021)
5.8 SEA Opioids Drug Consumption (2016-2021)
5.9 South America Opioids Drug Consumption (2016-2021)
5.10 Middle East Opioids Drug Consumption (2016-2021)
5.11 Oceania Opioids Drug Consumption (2016-2021)
5.12 Row Opioids Drug Consumption (2016-2021)
5.13 Distributors/Traders List
6 Global Opioids Drug Production, Revenue, Price Trend by Types
6.1 Global Opioids Drug Production and Market Share by Types (2016-2021)
6.1.1 Global Opioids Drug Production by Types (2016-2021)
6.1.2 Global Opioids Drug Production by Classification (2016-2021)
6.2 Global Opioids Drug Revenue (Million USD) and Market Share by Types (2016-2021)
6.2.1 Global Opioids Drug Revenue (Million USD) by Types (2016-2021)
6.2.2 Global Opioids Drug Revenue (Million USD) by Classification (2016-2021)
6.3 Global Opioids Drug Price by Type (2016-2021)
6.4 Global Opioids Drug Production Growth by Type (2016-2021)
7 Global Opioids Drug Market Share Analysis by Applications
7.1 Global Opioids Drug Consumption and Market Share by Applications (2016-2021)
7.2 Different Application Opioids Drug Product Driving Factors Analysis by Regions
7.3 North America Opioids Drug Consumption and Market Share by Applications (2016-2021)
7.4 EU Opioids Drug Consumption and Market Share by Applications (2016-2021)
7.5 CIS Opioids Drug Consumption and Market Share by Applications (2016-2021)
7.6 China Opioids Drug Consumption and Market Share by Applications (2016-2021)
7.7 India Opioids Drug Consumption and Market Share by Applications (2016-2021)
7.8 Japan Opioids Drug Consumption and Market Share by Applications (2016-2021)
7.9 SEA Opioids Drug Consumption and Market Share by Applications (2016-2021)
7.10 South America Opioids Drug Consumption and Market Share by Applications (2016-2021)
7.11 Middle East Opioids Drug Consumption and Market Share by Applications (2016-2021)
7.12 Oceania Opioids Drug Consumption and Market Share by Applications (2016-2021)
8 Global Opioids Drug Major Manufacturers Analysis
8.1 Teva
8.1.1 Teva Company Basic Information
8.1.2 Typical Product Picture, Application and Specification
8.1.3 Teva Opioids Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2016-2021)
8.1.4 Opioids Drug Company Profile
8.2 Purdue Pharma
8.2.1 Purdue Pharma Company Basic Information
8.2.2 Typical Product Picture, Application and Specification
8.2.3 Purdue Pharma Opioids Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2016-2021)
8.2.4 Opioids Drug Company Profile
8.3 Mallinckrodt
8.3.1 Mallinckrodt Company Basic Information
8.3.2 Typical Product Picture, Application and Specification
8.3.3 Hikma Opioids Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2016-2021)
8.3.4 Opioids Drug Company Profile
8.4 Amneal Pharma
8.4.1 Amneal Pharma Company Basic Information
8.4.1 Amneal Pharma Company Basic Information
8.4.3 Opioids Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2016-2021)
8.4.4 Opioids Drug Company Profile
8.5 Collegium
8.5.1 Collegium Company Basic Information
8.5.2 Typical Product Picture, Application and Specification
8.5.3 Opioids Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2016-2021)
8.5.4 Opioids Drug Company Profile
8.6 J&J
8.6.1 J&J Company Basic Information
8.6.2 Typical Product Picture, Application and Specification
8.6.3 Opioids Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2016-2021)
8.6.4 Opioids Drug Company Profile
8.7 Endo
8.7.1 Endo Company Basic Information
8.7.2 Typical Product Picture, Application and Specification
8.7.3 Opioids Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2016-2021)
8.7.4 Opioids Drug Company Profile
8.8 Pfizer
8.8.1 Pfizer Company Basic Information
8.8.2 Typical Product Picture, Application and Specification
8.8.3 Opioids Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2016-2021)
8.8.4 Opioids Drug Company Profile
8.9 INSYS
8.9.1 INSYS Company Basic Information
8.9.2 Typical Product Picture, Application and Specification
8.9.3 Opioids Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2016-2021)
8.9.4 Opioids Drug Company Profile
8.10 Mylan
8.10.1 Mylan Company Basic Information
8.10.2 Typical Product Picture, Application and Specification
8.10.3 Opioids Drug Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2016-2021)
8.10.4 Opioids Drug Company Profile
8.11 Hikma
8.12 Egalet
9. Marketing Strategy and Downstream Buyers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 B2B
9.1.4 B2C
9.2 Downstream Buyers
10 Opioids Drug Industry Future Trends and Competitive Products
10.1 The Latest Technology Development
10.2 Market Driven or Growth Reason
10.3 Relationship between Demand and Production
10.4 Competitive Products
11 New Project Investment Feasibility Analysis of Opioids Drug
11.1 New Project SWOT Analysis of Opioids Drug
11.2 New Project Investment Feasibility Analysis of Opioids Drug
11.2.1 Project Name
12.2.2 Investment Budget
11.2.3 Project Product Solutions
11.2.4 Project Schedule
12 Global Opioids Drug Market Forecast (2022-2027)
12.1 Global Opioids Drug Capacity, Production, Revenue Forecast (2022-2027)
12.1.1 Global Opioids Drug Capacity, Production and Growth Rate Forecast (2022-2027)
12.1.2 Global Opioids Drug Revenue (Million USD) and Growth Rate Forecast (2022-2027)
12.1.3 Global Opioids Drug Price and Trend Forecast (2022-2027)
12.2 Global Opioids Drug Production Forecast by Regions (2022-2027)
12.3 Regional Import, Export and Trade Forecast of Opioids Drug
12.4 Global Opioids Drug Consumption Forecast by Regions (2022-2027)
12.5 Global Opioids Drug Production, Revenue and Price Forecast by Type (2022-2027)
12.6 Global Opioids Drug Consumption Forecast by Application (2022-2027)
13 Research Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
